Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A randomized, double-blind, placebo-controlled parallel group study to evaluate efficacy and safety of lasmiditan tablet compared to Placebo in the acute treatment of Migraine
Epistemonikos ID: 7b860a7f7c69acad4b6a9b1e6621dbf531860f02
First added on: May 06, 2024